Cargando…

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity

The aim of the study was to investigate the relationship between intrinsic radiosensitivity and vascularity in carcinoma of the cervix given radiotherapy, and assess whether more refined prognostic information can be gained by combining the two parameters. A retrospective study was carried out on 74...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, R A, West, C M L, Wilks, D P, Logue, J P, Davidson, S E, Roberts, S A, Hunter, R D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362853/
https://www.ncbi.nlm.nih.gov/pubmed/10496365
http://dx.doi.org/10.1038/sj.bjc.6690700
_version_ 1782153557507571712
author Cooper, R A
West, C M L
Wilks, D P
Logue, J P
Davidson, S E
Roberts, S A
Hunter, R D
author_facet Cooper, R A
West, C M L
Wilks, D P
Logue, J P
Davidson, S E
Roberts, S A
Hunter, R D
author_sort Cooper, R A
collection PubMed
description The aim of the study was to investigate the relationship between intrinsic radiosensitivity and vascularity in carcinoma of the cervix given radiotherapy, and assess whether more refined prognostic information can be gained by combining the two parameters. A retrospective study was carried out on 74 patients with locally advanced carcinoma of the cervix. Formalin-fixed, paraffin-embedded tumour biopsies were stained with anti-factor VIII using immunohistochemistry. Vascularity was scored using the intra-tumour microvessel density (IMD), or ‘hot-spot’, technique. For the same patients, the measurement of intrinsic radiosensitivity (SF2) had been made previously on the same pretherapy samples. Patients were stratified by the median IMD and SF2 scores. Women with radioresistant and highly vascular tumours had poorer 5-year survival (P = 0.0005, P = 0.035 respectively) and local control (P = 0.012, P = 0.077 respectively) than those with radiosensitive and poorly vascular tumours. No significant correlation was seen between IMD and SF2. Multivariate analysis (including tumour stage and patient age) showed that only SF2 and IMD were significant prognostic factors for survival. Patients with both a radioresistant and highly vascular tumour had a 5-year survival level of 18% compared to 77% for those patients with a radiosensitive and poorly vascularized tumour. Tumour angiogenesis and cellular radiosensitivity are independent prognostic factors for cervix carcinoma treated with radiotherapy. Allowing for tumour radiosensitivity increases the prognostic significance of vascularity measurements in cervix tumours. © 1999 Cancer Research Campaign
format Text
id pubmed-2362853
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23628532009-09-10 Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity Cooper, R A West, C M L Wilks, D P Logue, J P Davidson, S E Roberts, S A Hunter, R D Br J Cancer Regular Article The aim of the study was to investigate the relationship between intrinsic radiosensitivity and vascularity in carcinoma of the cervix given radiotherapy, and assess whether more refined prognostic information can be gained by combining the two parameters. A retrospective study was carried out on 74 patients with locally advanced carcinoma of the cervix. Formalin-fixed, paraffin-embedded tumour biopsies were stained with anti-factor VIII using immunohistochemistry. Vascularity was scored using the intra-tumour microvessel density (IMD), or ‘hot-spot’, technique. For the same patients, the measurement of intrinsic radiosensitivity (SF2) had been made previously on the same pretherapy samples. Patients were stratified by the median IMD and SF2 scores. Women with radioresistant and highly vascular tumours had poorer 5-year survival (P = 0.0005, P = 0.035 respectively) and local control (P = 0.012, P = 0.077 respectively) than those with radiosensitive and poorly vascular tumours. No significant correlation was seen between IMD and SF2. Multivariate analysis (including tumour stage and patient age) showed that only SF2 and IMD were significant prognostic factors for survival. Patients with both a radioresistant and highly vascular tumour had a 5-year survival level of 18% compared to 77% for those patients with a radiosensitive and poorly vascularized tumour. Tumour angiogenesis and cellular radiosensitivity are independent prognostic factors for cervix carcinoma treated with radiotherapy. Allowing for tumour radiosensitivity increases the prognostic significance of vascularity measurements in cervix tumours. © 1999 Cancer Research Campaign Nature Publishing Group 1999-09 /pmc/articles/PMC2362853/ /pubmed/10496365 http://dx.doi.org/10.1038/sj.bjc.6690700 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Cooper, R A
West, C M L
Wilks, D P
Logue, J P
Davidson, S E
Roberts, S A
Hunter, R D
Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
title Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
title_full Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
title_fullStr Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
title_full_unstemmed Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
title_short Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
title_sort tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362853/
https://www.ncbi.nlm.nih.gov/pubmed/10496365
http://dx.doi.org/10.1038/sj.bjc.6690700
work_keys_str_mv AT cooperra tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity
AT westcml tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity
AT wilksdp tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity
AT loguejp tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity
AT davidsonse tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity
AT robertssa tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity
AT hunterrd tumourvascularityisasignificantprognosticfactorforcervixcarcinomatreatedwithradiotherapyindependencefromtumourradiosensitivity